Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Ladak K, Crowther M. N Engl J Med 2022;386:1766-1767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ladak K, Crowther M. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:1766-1767.
PMID: 35507491